This is a Validated Antibody Database (VAD) review about mouse Mcl1, based on 55 published articles (read how Labome selects the articles), using Mcl1 antibody in all methods. It is aimed to help Labome visitors find the most suited Mcl1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mcl1 synonym: AW556805; Mcl-1

Abcam
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:1000; loading ...; fig 4b, s1b
Abcam Mcl1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:1000 (fig 4b, s1b). Biol Open (2019) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:1000; loading ...; fig 5b
Abcam Mcl1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:1000 (fig 5b). Front Neurosci (2019) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500; loading ...; fig 4b
Abcam Mcl1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:500 (fig 4b). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; loading ...; fig 3a
Abcam Mcl1 antibody (ABcam, ab32087) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500; fig 2
Abcam Mcl1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:500 (fig 2). Nat Commun (2016) ncbi
domestic rabbit monoclonal (Y37)
  • immunohistochemistry; human; 1:40; tbl 2
In order to evaluate the reliance on EBV or NF-kappaB signaling instead of B-cell receptor signaling in regards to complete phenotypic characterization of PTLD, Abcam Mcl1 antibody (Abcam, ab32087) was used in immunohistochemistry on human samples at 1:40 (tbl 2). Hematol Oncol (2017) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; fig 6
Abcam Mcl1 antibody (Abcam, ab32087) was used in western blot on human samples (fig 6). Genetics (2015) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500; fig 7
Abcam Mcl1 antibody (Abcam, Y37) was used in western blot on human samples at 1:500 (fig 7). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:1000
Abcam Mcl1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:1000. Apoptosis (2014) ncbi
domestic rabbit monoclonal (Y37)
  • western blot; human; 1:500
Abcam Mcl1 antibody (Abcam, ab32087) was used in western blot on human samples at 1:500. Autophagy (2013) ncbi
Rockland Immunochemicals
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4a
Rockland Immunochemicals Mcl1 antibody (Rockland Immunochemicals, 600-401-394) was used in western blot on mouse samples (fig 4a). Autophagy (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1d
  • western blot; human; loading ...; fig 3a
Rockland Immunochemicals Mcl1 antibody (Rockland, 600-401-394) was used in western blot on mouse samples (fig 1d) and in western blot on human samples (fig 3a). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s5
Rockland Immunochemicals Mcl1 antibody (Rockland, 200-401-CR9) was used in western blot on mouse samples (fig s5). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 3d
Rockland Immunochemicals Mcl1 antibody (Rockland, 600-401-394) was used in western blot on mouse samples (fig 3d). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:200; fig 7
  • western blot; mouse; fig 7
Rockland Immunochemicals Mcl1 antibody (Rockland, 600-401-394) was used in immunocytochemistry on mouse samples at 1:200 (fig 7) and in western blot on mouse samples (fig 7). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 9
Rockland Immunochemicals Mcl1 antibody (Rockland, 600-401-394) was used in western blot on mouse samples (fig 9). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
Rockland Immunochemicals Mcl1 antibody (Rockland, 600-401-394) was used in western blot on mouse samples (fig 6). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1
Rockland Immunochemicals Mcl1 antibody (Rockland, 600-401-394S) was used in western blot on mouse samples (fig 1). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
In order to study the effect of parkin deletion and acute knockdown on acetaminophen-induced mitophagy and liver injury in mice, Rockland Immunochemicals Mcl1 antibody (Rockland, 600-401-394) was used . J Biol Chem (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (RC13)
  • western blot; human
In order to assess the effect of matrine on STAT3 signaling in cholangiocarcinoma cells, Santa Cruz Biotechnology Mcl1 antibody (Santa Cruz, sc-56152) was used in western blot on human samples . Pharmacol Rep (2015) ncbi
Boster
domestic rabbit polyclonal
  • immunoprecipitation; human; loading ...; fig 1c
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig s1a
  • immunocytochemistry; mouse; loading ...; fig 7a
  • western blot; mouse; loading ...; fig 7g
Boster Mcl1 antibody (oster Biological Technology, PB9132) was used in immunoprecipitation on human samples (fig 1c), in immunocytochemistry on human samples (fig 2a), in western blot on human samples (fig s1a), in immunocytochemistry on mouse samples (fig 7a) and in western blot on mouse samples (fig 7g). J Cell Sci (2017) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Invitrogen Mcl1 antibody (Invitrogen, PA5-27597) was used in western blot on human samples (fig 2a). Oncotarget (2018) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; mouse; fig 1c
MilliporeSigma Mcl1 antibody (Sigma, SAB4504259) was used in western blot on mouse samples (fig 1c). J Cell Biol (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples at 1:1000 (fig 1a). elife (2020) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 3s2e
Cell Signaling Technology Mcl1 antibody (CST, 5453) was used in western blot on human samples (fig 3s2e). elife (2019) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 4c). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (D35A5)
  • other; human; loading ...; fig 4c
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 3d). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; loading ...; fig s4a
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples at 1:1000 (fig s4a). Nat Med (2017) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; loading ...; fig 8a
Cell Signaling Technology Mcl1 antibody (cell signalling, 5453) was used in western blot on human samples at 1:1000 (fig 8a). Int J Oncol (2017) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 10a
In order to study chaperome complexes in a large set of tumor specimens, Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 10a). Nature (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples at 1:1000 (fig st1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Mcl1 antibody (Cell Signaling, 4579) was used in western blot on human samples at 1:1000 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 7b). Cancer Res (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig s4b
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig s4b). Cell Death Dis (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 4
Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 7a
In order to propose that ABHD5 has a PNPLA2-independent function in regulating autophagy and tumorigenesis, Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 7a). Autophagy (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 4b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology Mcl1 antibody (Cell Signaling Tech, 5453S) was used in western blot on human samples at 1:1000 (fig 5). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; fig 2
Cell Signaling Technology Mcl1 antibody (Cell Signaling Technolog, 5453) was used in western blot on mouse samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; 1:1000; fig 1e
In order to evaluate the antitumor activity of the pan-HDAC inhibitor, panobinostat, in mice, Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on mouse samples at 1:1000 (fig 1e). Int J Cancer (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:1000; fig 1
In order to investigate the effect of Obatoclax in esophageal cancer cells, Cell Signaling Technology Mcl1 antibody (Cell Signaling Tech, 5453) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 6
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 5
In order to examine the effects of brusatol on the cellular proteome in a mutant non-small cell lung cancer cell line, Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples (fig 5). Mol Cell Proteomics (2016) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; fig 5a
Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453) was used in western blot on mouse samples (fig 5a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; 1:500; fig 3
In order to characterize immunogenic PEL cell death, revertion of PEL-induced immune suppression, and stimulation of DCs all triggered by capsaicin, Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453P) was used in western blot on human samples at 1:500 (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 2b
  • western blot; mouse; fig 2a
In order to utilize an E-mu-TCL1 mouse model to study miR-181b as a therapeutic agent for chronic lymphocytic leukemia, Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples (fig 2b) and in western blot on mouse samples (fig 2a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; 1:200; fig 9
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on mouse samples at 1:200 (fig 9). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig s7
Cell Signaling Technology Mcl1 antibody (CST, 5453) was used in western blot on human samples (fig s7). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 2a
Cell Signaling Technology Mcl1 antibody (Cell Signaling, D35A5) was used in western blot on human samples (fig 2a). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 5
In order to elucidate how PLK1 regulates cell survival during mTORC1 hyperactivation, Cell Signaling Technology Mcl1 antibody (Cell signaling, 5453) was used in western blot on human samples (fig 5). Cell Cycle (2015) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human
Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human
Cell Signaling Technology Mcl1 antibody (Cell Signaling Technologies, 5453) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse; fig 9
Cell Signaling Technology Mcl1 antibody (Cell Signaling Technology, 5453) was used in western blot on mouse samples (fig 9). J Neurosci (2013) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; mouse
Cell Signaling Technology Mcl1 antibody (Cell Signaling, D35A5) was used in western blot on mouse samples . Mol Cancer Ther (2013) ncbi
domestic rabbit monoclonal (D35A5)
  • western blot; human; fig 5
Cell Signaling Technology Mcl1 antibody (Cell Signaling, 5453) was used in western blot on human samples (fig 5). Cell Cycle (2013) ncbi
Articles Reviewed
  1. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  2. Tian M, Gong W, Guo J. Long non-coding RNA SNHG1 indicates poor prognosis and facilitates disease progression in acute myeloid leukemia. Biol Open. 2019;8: pubmed publisher
  3. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed publisher
  4. Wang S, Ni H, Chao X, Wang H, Bridges B, Kumer S, et al. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis. Autophagy. 2019;15:1954-1969 pubmed publisher
  5. Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, et al. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int. 2019;19:32 pubmed publisher
  6. Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J, et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44 pubmed publisher
  7. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed publisher
  8. Pearce M, Gamble J, Kopparapu P, O Donnell E, Mueller M, Jang H, et al. Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells. Oncotarget. 2018;9:26072-26085 pubmed publisher
  9. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  10. Sorokina I, Denisenko T, Imreh G, Tyurin Kuzmin P, Kaminskyy V, Gogvadze V, et al. Involvement of autophagy in the outcome of mitotic catastrophe. Sci Rep. 2017;7:14571 pubmed publisher
  11. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher
  12. Nikhil K, Shah K. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease. J Cell Sci. 2017;130:3023-3039 pubmed publisher
  13. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed publisher
  14. Adams C, Kim A, Mitra R, Choi J, Gong J, Eischen C. BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest. 2017;127:635-650 pubmed publisher
  15. Wakatsuki S, Tokunaga S, Shibata M, Araki T. GSK3B-mediated phosphorylation of MCL1 regulates axonal autophagy to promote Wallerian degeneration. J Cell Biol. 2017;216:477-493 pubmed publisher
  16. Rodina A, Wang T, Yan P, Gomes E, Dunphy M, Pillarsetty N, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397-401 pubmed publisher
  17. Myasnikov A, Kundhavai Natchiar S, Nebout M, Hazemann I, Imbert V, Khatter H, et al. Structure-function insights reveal the human ribosome as a cancer target for antibiotics. Nat Commun. 2016;7:12856 pubmed publisher
  18. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  19. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  20. Klingbeil O, Lesche R, Gelato K, Haendler B, Lejeune P. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365 pubmed publisher
  21. Park S, Jo D, Jo S, Shin D, Shim S, Jo Y, et al. Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death. Oncotarget. 2016;7:65957-65967 pubmed publisher
  22. Peng Y, Miao H, Wu S, Yang W, Zhang Y, Xie G, et al. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2. Autophagy. 2016;12:2167-2182 pubmed
  23. Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, et al. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. 2016;7:56338-56354 pubmed publisher
  24. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  25. Gao Z, Liu Z, Bi M, Zhang J, Han Z, Han X, et al. Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro. Exp Ther Med. 2016;11:1700-1706 pubmed
  26. Wang W, Zhan M, Li Q, Chen W, Chu H, Huang Q, et al. FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression. Oncotarget. 2016;7:34617-29 pubmed publisher
  27. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  28. Waldeck K, Cullinane C, Ardley K, Shortt J, Martin B, Tothill R, et al. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model. Int J Cancer. 2016;139:194-204 pubmed publisher
  29. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed publisher
  30. Lopez J, Bessou M, Riley J, Giampazolias E, Todt F, Rochegüe T, et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun. 2016;7:10538 pubmed publisher
  31. Thornton T, Delgado P, Chen L, Salas B, Krementsov D, Fernández M, et al. Inactivation of nuclear GSK3β by Ser(389) phosphorylation promotes lymphocyte fitness during DNA double-strand break response. Nat Commun. 2016;7:10553 pubmed publisher
  32. Menter T, Dickenmann M, Juskevicius D, Steiger J, Dirnhofer S, Tzankov A. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling. Hematol Oncol. 2017;35:187-197 pubmed publisher
  33. Wang S, Ni H, Dorko K, Kumer S, Schmitt T, Nawabi A, et al. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury. Oncotarget. 2016;7:17681-98 pubmed publisher
  34. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  35. Vartanian S, Ma T, Lee J, Haverty P, Kirkpatrick D, Yu K, et al. Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis. Mol Cell Proteomics. 2016;15:1220-31 pubmed publisher
  36. Wang J, De Veirman K, De Beule N, Maes K, De Bruyne E, Van Valckenborgh E, et al. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget. 2015;6:43992-4004 pubmed publisher
  37. Sochalska M, Ottina E, Tuzlak S, Herzog S, Herold M, Villunger A. Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival. Cell Death Differ. 2016;23:628-39 pubmed publisher
  38. Bailey M, Singh T, Mero P, Moffat J, Hieter P. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint. Genetics. 2015;201:885-95 pubmed publisher
  39. Granato M, Gilardini Montani M, Filardi M, Faggioni A, Cirone M. Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression. Oncotarget. 2015;6:29543-54 pubmed publisher
  40. Bresin A, Callegari E, D Abundo L, Cattani C, Bassi C, Zagatti B, et al. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Oncotarget. 2015;6:19807-18 pubmed
  41. Schuler F, Baumgartner F, Klepsch V, Chamson M, Müller Holzner E, Watson C, et al. The BH3-only protein BIM contributes to late-stage involution in the mouse mammary gland. Cell Death Differ. 2016;23:41-51 pubmed publisher
  42. Nagata T, Yasukawa H, Kyogoku S, Oba T, Takahashi J, Nohara S, et al. Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules. PLoS ONE. 2015;10:e0127942 pubmed publisher
  43. Martínez A, Sesé M, Losa J, Robichaud N, Sonenberg N, Aasen T, et al. Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches. PLoS ONE. 2015;10:e0123352 pubmed publisher
  44. Gupta J, Igea A, Papaioannou M, López Casas P, Llonch E, Hidalgo M, et al. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors. Oncotarget. 2015;6:8539-51 pubmed
  45. Williams J, Ni H, Haynes A, Manley S, Li Y, Jaeschke H, et al. Chronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in Mice. J Biol Chem. 2015;290:10934-46 pubmed publisher
  46. Yang N, Han F, Cui H, Huang J, Wang T, Zhou Y, et al. Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling. Pharmacol Rep. 2015;67:388-93 pubmed publisher
  47. Lu K, Fang X, Feng L, Jiang Y, Zhou X, Liu X, et al. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Lett. 2015;359:250-8 pubmed publisher
  48. Valianou M, Cox A, Pichette B, Hartley S, Paladhi U, Astrinidis A. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Cell Cycle. 2015;14:399-407 pubmed publisher
  49. Waitkus M, Chandrasekharan U, Willard B, Tee T, Hsieh J, Przybycin C, et al. Signal integration and gene induction by a functionally distinct STAT3 phosphoform. Mol Cell Biol. 2014;34:1800-11 pubmed publisher
  50. Yoon H, Choi Y, Song J, Do I, Kang S, Ko Y, et al. Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines. PLoS ONE. 2014;9:e88587 pubmed publisher
  51. Annibaldi A, Heulot M, Martinou J, Widmann C. TAT-RasGAP317-326-mediated tumor cell death sensitization can occur independently of Bax and Bak. Apoptosis. 2014;19:719-33 pubmed publisher
  52. Crowther A, Gama V, Bevilacqua A, Chang S, Yuan H, Deshmukh M, et al. Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. J Neurosci. 2013;33:18098-108 pubmed publisher
  53. Peng Y, Shi Y, Ding Z, Ke A, Gu C, Hui B, et al. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy. 2013;9:2056-68 pubmed publisher
  54. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed publisher
  55. Carra E, Barbieri F, Marubbi D, Pattarozzi A, Favoni R, Florio T, et al. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures. Cell Cycle. 2013;12:491-500 pubmed publisher